This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paolo Liberini, MD; Maurizio Memo, PhD
PierFranco Spano Brescia University School of Medicine Brescia, Italy

JAMA. 1995;274(15):1199.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—A primary goal of research related to Alzheimer's disease (AD) is to characterize subtypes of the disease amenable to specific therapeutic interventions. Recent investigations indicated that concomitant or independently occurring Lewy body (LB) pathology represents one of the largest variants of clinically diagnosed AD. This neuropathological entity is characterized by eosinophilic intracytoplasmic inclusion bodies disseminated in the neocortex, limbic areas, and brain stem nuclei and usually occurring with pathologic changes characteristic of moderate AD. Although clinical criteria for the identification of LB dementia (fluctuation in impairment of cognitive functions, hallucinations often leading to paranoid delusions, unexplained falls and/or loss of consciousness, extrapyramidal features, and neuroleptic hypersensitivity) are not firmly established, interest in LB dementia as an independent nosographic entity¹ is growing.

The postmortem examination of LB-affected brains provides a set of neuropathological features² that more clearly, although not unequivocally, differentiate LB dementia from typical, neuropathologically . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?